AptarGroup, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| ATR | STVN | WST | AVTR | SOLV | ICUI | |
|---|---|---|---|---|---|---|
| Market cap | 9.31B | 3.67B | 28.48B | 10.60B | 15.21B | 4.32B |
| P/E (TTM) | 35.5 | 22.8 | 45.9 | 31.3 | 10.9 | 145.1 |
| Forward P/E | 23.7 | 16.3 | 39.3 | 17.6 | 12.3 | 17.9 |
| Price/book | 3.6 | 2.0 | 9.6 | 1.8 | 3.2 | 2.0 |
| Dividend yield | 1.36% | 0.46% | 0.25% | — | — | — |
| 1-year change | +23.14% | −43.60% | +43.54% | +34.63% | +34.81% | +33.12% |
| Today | +3.20% | −4.68% | +0.44% | +0.38% | +5.42% | +6.67% |
The closest companies by business and industry (Medical Instruments & Supplies). Prices may be delayed up to 15 min.
Latest news
All ATR news ›AptarGroup, Inc. $ATR Stock Sold by Boston Trust Walden Corp
MarketBeat AptarGroup, Inc. $ATR Stock Sold by Boston Trust Walden Corp Boston Trust Walden Corp trimmed its holdings in AptarGroup, Inc. (NYSE:ATR - Free Report) by 11.3% in the third quarter, according to the company in its most recent
Aptar: 3 Key Takeaways for Long-Term Investors
Pharma core sales grew 8% after excluding the $65 million annual headwind from emergency medicine destocking, where distributors reduce existing inventory rather than order new products. Management pointed to expansion across central…
APTIV ($APTV) Releases Q3 2026 Earnings
APTIV ($APTV) posted quarterly earnings results for Q3 2026 on Tuesday, November 3rd. The company reported earnings of $1.42 per share, beating estimates of $1.35 by $0.07. The company also reported revenue of $3,199,000,000, missing…
Livingbridge backs launch of accounting group Apteus after seven acquisitions
Apteus provides accountancy, audit, tax and specialist advisory services to small and medium-sized businesses. GrowthCurve Capital takes majority stake in medication access platform TailorMed Permira hires former S&P Global CEO Douglas…
AptarGroup (NYSE:ATR) Stock Price Breaks Above 200-Day Moving Average - Here's Why
AptarGroup, Inc. (NYSE:ATR - Get Free Report) crossed above its 200-day moving average during trading on Monday. The stock has a 200-day moving average of $126.83 and traded as high as $127.68. AptarGroup shares last traded at $127.2090,…
More from 1 other outlet
Aptar Pharma Acquires PULMOTREE To Expand Pulmonary Drug Delivery Platform
Aptar Pharma has acquired PULMOTREE, a Munich-based life sciences company focused on pulmonary drug delivery technologies, expanding its respiratory product portfolio with a non-propellant liquid inhaler platform. Kolibri is designed for…
NeuroOne Releases CNS Drug Delivery White Paper Ahead of Planned Fiscal Year-End Availability of the StereoCED(TM) Platform
ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness. The white paper highlights how advances in cell and ... White Paper Highlights How…
AptarGroup Edges Past Q3 2026 Estimates, Posts $1.52 EPS, Revenue Up 6%
Earnings beat delivered. AptarGroup, Inc. (NYSE:ATR) reported Q3 2026 adjusted earnings of $1.52 per share, topping Wall Street's consensus estimate of $1.4... The post AptarGroup Edges Past Q3 2026 Estimates, Posts $1.52 EPS, Revenue Up…
AptarGroup Releases Q3 2026 Financial Results
AptarGroup, Inc. The post AptarGroup Releases Q3 2026 Financial Results first appeared on Alphastreet. AlphaStreet Newsdesk powered by AlphaStreet Intelligence AptarGroup, Inc. (NYSE: ATR) delivered a solid third quarter, with adjusted…
More from 1 other outlet
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- marketscreener.com12
- seekingalpha.com5
- marketbeat.com4
- themarketsdaily.com4
- news.alphastreet.com2
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 46 articles, not a forecast.